These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1399206)

  • 1. Recessive dystrophic epidermolysis bullosa treated with phenytoin.
    Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
    Int J Dermatol; 1992 Oct; 31(10):730-2. PubMed ID: 1399206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
    Caldwell-Brown D; Stern RS; Lin AN; Carter DM
    N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.
    Bauer EA; Cooper TW; Tucker DR; Esterly NB
    N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa.
    Kuo DJ; Bruckner AL; Jeng MR
    Pediatr Dermatol; 2006; 23(6):580-5. PubMed ID: 17156003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermolysis bullosa in the eastern province of Saudi Arabia.
    Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
    Int J Dermatol; 1993 Aug; 32(8):579-81. PubMed ID: 8407073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment.
    Cooper TW; Bauer EA
    Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa.
    Inamadar AC
    Dermatol Ther; 2020 Nov; 33(6):e14279. PubMed ID: 32888385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophic epidermolysis bullosa inversa: a case report.
    Altomare GF; Polenghi M; Pigatto PD; Nazzaro V; Piattoni F
    Dermatologica; 1990; 181(2):145-8. PubMed ID: 2173667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of COL7A1 mutations in two patients with recessive dystrophic epidermolysis bullosa from Peru.
    Saeidian AH; Youssefian L; Rosales-Solis GM; Vahidnezhad H; Atanasova VS; Uitto J; South AP; Salas-Alanis JC
    Clin Exp Dermatol; 2018 Aug; 43(6):719-722. PubMed ID: 29427316
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosa.
    Vaidya S; Tyring SK; Johnson LB; Fine JD
    Arch Dermatol; 1991 Oct; 127(10):1524-7. PubMed ID: 1929459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
    Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
    J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
    Bodemer C; Tchen SI; Ghomrasseni S; Séguier S; Gaultier F; Fraitag S; de Prost Y; Godeau G
    J Invest Dermatol; 2003 Aug; 121(2):273-9. PubMed ID: 12880418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of collagenase and stromelysin in skin fibroblasts derived from dystrophic epidermolysis bullosa.
    Sugawara T; Nomura K; Hashimoto I
    J Dermatol Sci; 1993 Oct; 6(2):172-80. PubMed ID: 8274463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional epidermolysis bullosa. Treatment with phenytoin.
    Guill MF; Wray BB; Rogers RB; Yancey KB; Allen BS
    Am J Dis Child; 1983 Oct; 137(10):992-4. PubMed ID: 6613946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent elevation of serum interleukin-6 and serum amyloid A levels in patients with recessive dystrophic epidermolysis bullosa.
    Morizane S; Mizuno K; Takiguchi T; Ogita S; Nishida Y; Kawakami Y; Iwatsuki K
    Eur J Dermatol; 2017 Feb; 27(1):80-81. PubMed ID: 27777188
    [No Abstract]   [Full Text] [Related]  

  • 19. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose tocopherol acetate therapy in epidermolysis bullosa siblings of the Cockayne-Touraine type.
    Shirakata Y; Shiraishi S; Sayama K; Shinmori H; Miki Y
    J Dermatol; 1993 Nov; 20(11):723-5. PubMed ID: 8300945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.